机构

• 上海药物研究所 [340]

采集方式

• OAI收割 [340]

内容类型

• 期刊论文 [328]
• 会议论文 [12]

发表日期

• 2024 [4]
• 2023 [27]
• 2022 [25]
• 2021 [44]
• 2020 [29]
• 2019 [24]
• 更多

学科主题

• Chemistry [1]
• Oncology [1]
• Pharmacolo... [1]
• Plant Scie... [1]

筛选

浏览/检索结果: 共340条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 7-Dehydrocholesterol dictates ferroptosis sensitivity 期刊论文  OAI收割 NATURE, 2024, 卷号: 626, 期号: 7998, 页码: 29 作者:  Li, Yaxu;  Ran, Qiao;  Duan, Qiuhui;  Jin, Jiali;  Wang, Yanjin   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/09 Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 16 作者:  Cheng, Chen;  Ren, Chao;  Li, Mu-zi;  Liu, Yi-hui;  Yao, Ren-qi   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/02/27 Traditional Chinese medicine  XueBiJing  sepsis  mortality  pharmacokinetic compatibility  polypharmacology   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies 期刊论文  OAI收割 CELL, 2024, 卷号: 187, 期号: 1, 页码: 49 作者:  Liu, Qian;  Zhang, Jing;  Guo, Chenchen;  Wang, Mengcheng;  Wang, Chenfei   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/02/27 Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 卷号: 96, 页码: 12 作者:  Song, Zhaoxiang;  Lu, Dan;  Sun, Jun;  Ye, Yangliang;  Fang, Jiahui   |  收藏  |  浏览/下载：27/0  |  提交时间：2024/01/16 GPR35  IBD  Lodoxamide   Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4748-4764 作者:  Liu, Yingqiang;  Zhan, Zhengsheng;  Kang, Zhuang;  Li, Mengyuan;  Lv, Yongcong   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/01/26 Small molecule inhibitor  Tumor microenvironment  Immune-checkpoint  immune-deficient mouse models  including temozolomide (TMZ) insensitive tumors. Notably   Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933 作者:  Fang, Feifei;  Dai, Yang;  Wang, Hao;  Ji, Yinchun;  Liang, Xuewu   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/01/26 derivatives  Antitumor drug development  Potential AXL inhibitor  Antitumor activity  Structure-based drug design  Fused-pyrazolone carboxamide   Original Research Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma 期刊论文  OAI收割 EUROPEAN JOURNAL OF CANCER, 2023, 卷号: 194, 页码: 9 作者:  He, Wen-Zhuo;  Huang, Yu-Hua;  Hu, Wan-Ming;  Wang, Fang;  Xu, Yu-Xia   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/12/11 Epstein-Barr virus  Intrahepatic cholangiocarcinoma  Programmed cell death protein 1  Immunotherapy   Ligand activation mechanisms of human KCNQ2 channel 期刊论文  OAI收割 Nature communications, 2023, 卷号: 14, 期号: 1, 页码: 6632 作者:  Ma, Demin;  Zheng, Yueming;  Li, Xiaoxiao;  Zhou, Xiaoyu;  Yang, Zhenni   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/03/26 Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol 期刊论文  OAI收割 ACS CHEMICAL NEUROSCIENCE, 2023, 卷号: 14, 期号: 21, 页码: 3941-3958 作者:  Ge, Haixia;  Ji, Beihong;  Fang, Jiahui;  Wang, Jiayang;  Li, Jing   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/11 function-based ligand design  receptor-ligandbinding profile  CB1/CB2  structure-activityrelationship